Natural Partners

Natural Partners Fullscript in its US$25 million ($34 million) Series B financing round.

Client

Natural Partners

Value

US $25 Million ($34 Million)

Service

Emerging and High Growth Companies

Date Closed

May 2019

Industry

Venture Capital

Lead Office

Toronto


May 21, 2019, Natural Partners Fullscript raised US$25 million ($34 million) in a Series B financing round. The round was led by Kayne Partners, the growth equity affiliate of U.S. alternative investment firm Kayne Anderson Capital Advisors, and included participation from other investors. The proceeds will be used to scale Fullscript, which enables healthcare practitioners to dispense nutritional supplements to their patients through an e-prescribing platform.

Natural Partners Fullscript engages in distribution of healthcare products through its online supplement dispensing platform called Fullscript. Its products include nutritional supplements, vitamins and minerals, herbs, homeopathy, personal care and specialty, acupuncture and oriental medicine, prescription products, animal health, and other brand products.

Kayne Partners is a principal investment firm based in United States.

Osler, Hoskin & Harcourt LLP represented Fullscript with a team consisting of Chad Bayne, David Jamieson, Jeremy Wu (Emerging and High Growth Companies), and Dov Begun (Tax).


Team
Chad Bayne
Key Contact

Chad Bayne

Partner, Emerging and High Growth Companies

Dov  Begun

Dov Begun

Partner, Taxation

David Jamieson

David Jamieson

Associate, Emerging and High Growth Companies

Jeremy Wu

Jeremy Wu

Associate, Corporate